Journal
FREE RADICAL BIOLOGY AND MEDICINE
Volume 208, Issue -, Pages 672-683Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.freeradbiomed.2023.09.020
Keywords
Gamma-glutamyl transpeptidase; GGT inhibitors; Glutathione; Redox homeostasis; Oxidative stress
Ask authors/readers for more resources
GGT is an enzyme located on the outer membrane of the cells and plays a key role in regulating glutathione metabolism. It is upregulated in inflammatory conditions and various human tumors, and is involved in physiological disorders related to oxidative stress. This review focuses on the structure and function of human GGT, and discusses its potential as a target for drugs to alleviate oxidative stress-related diseases. The development of new GGT inhibitors and their potential clinical use is also discussed. GGT is considered a potential moonlighting protein due to its pleiotropic activities and evolved functions.
Gamma-glutamyl transpeptidase (GGT) is an enzyme located on the outer membrane of the cells where it regulates the metabolism of glutathione (GSH), the most abundant intracellular antioxidant thiol. GGT plays a key role in the control of redox homeostasis, by hydrolyzing extracellular GSH and providing the cell with the recovery of cysteine, which is necessary for de novo intracellular GSH and protein biosynthesis. Therefore, the upregulation of GGT confers to the cell greater resistance to oxidative stress and the advantage of growing fast. Indeed, GGT is upregulated in inflammatory conditions and in the progression of various human tumors and it is involved in many physiological disorders related to oxidative stress, such as cardiovascular disease and diabetes. Currently, increased GGT expression is considered a marker of liver damage, cancer, and low-grade chronic inflammation.This review addresses the current knowledge on the structure-function relationship of GGT, focusing on human GGT, and provides information on the pleiotropic biological role and relevance of the enzyme as a target of drugs aimed at alleviating oxidative stress-related diseases. The development of new GGT inhibitors is critically discussed, as are the advantages and disadvantages of their potential use in clinics. Considering its pleiotropic activities and evolved functions, GGT is a potential moonlighting protein.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available